Purification of supercoiled p53-encoding plasmid using an arginine-modified macroporous support

Area of Science:

• Biotechnology
• Biochemistry
• Materials Science

Background:

• Supercoiled plasmid DNA (pDNA) is essential for effective cancer gene therapy.
• Current purification methods using arginine-agarose have limitations in binding capacity and reusability.
• Developing efficient and scalable pDNA purification techniques is critical for therapeutic applications.

Purpose of the Study:

• To develop a novel arginine-modified macroporous support for enhanced purification of supercoiled pDNA (sc pDNA).
• To evaluate the binding capacity, selectivity, and robustness of the new support for pDNA purification.
• To assess the economic feasibility of the developed purification method for potential scale-up.

Main Methods:

• Macroporous support was modified with arginine and characterized using SEM, EDX, and FTIR.
• The arginine-modified support was used for the purification of sc p53-pDNA.
• Purification of plasmids of different sizes was performed by adjusting experimental conditions.
• Dynamic binding capacity was compared to commercial arginine-agarose matrices.

Main Results:

• The arginine-modified macroporous support effectively isolated sc p53-pDNA.
• The purification method demonstrated robustness with plasmids of varying sizes.
• A >50% improvement in pDNA binding capacity was achieved compared to commercial arginine-agarose.
• The results suggest potential economic feasibility for large-scale purification.

Conclusions:

• Arginine-modified macroporous support is a highly effective material for sc pDNA purification.
• The enhanced binding capacity and robustness offer significant advantages over existing methods.
• This technology holds promise for cost-effective, large-scale production of therapeutic pDNA.